Standout Papers

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy 2015 2026 2018 2022 507
  1. Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy (2015)
    Jeffrey G. Gross, Adam R. Glassman et al. JAMA

Immediate Impact

1 from Science/Nature 69 standout
Sub-graph 1 of 21

Citing Papers

A systems view of the vascular endothelium in health and disease
2024 Standout
Gene therapy for neovascular age-related macular degeneration by subretinal delivery of RGX-314: a phase 1/2a dose-escalation study
2024 Standout
2 intermediate papers

Works of Seidu Inusah being referenced

Panretinal Photocoagulation vs Intravitreous Ranibizumab for Proliferative Diabetic Retinopathy
2015 Standout

Author Peers

Author Last Decade Papers Cites
Seidu Inusah 276 123 59 484 481 16 1.2k
Cody Hamilton 369 175 124 254 193 32 1.3k
Jonghyeon Kim 79 88 89 301 653 28 1.3k
Michael Crager 226 63 191 121 64 38 993
Thomas Schmelter 16 25 19 352 426 44 1.0k
Jingyuan Yang 262 1092 72 299 86 23 1.5k
David Mackintosh 202 94 41 51 42 27 1.2k
Avinash V. Varadarajan 125 44 100 1001 681 10 1.5k
Vineet K. Raghu 286 79 73 238 37 40 1.0k
Kristin K. Snow 23 32 835 238 397 15 1.4k
Gabriella Moraes 39 73 93 815 351 22 1.5k

All Works

Loading papers...

Rankless by CCL
2026